Search

Search Results
Results 1191 - 1200 of 1414 for Active treatment
  • Olamlo HCT
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Olamlo HCT (Olmesartan medoxomil, amlodipine and hydrochlorothiazide) intended for persons living in Australia.
  • Noten
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Noten intended for persons living in Australia.
  • Flosix
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Flosix intended for persons living in Australia.
  • Pyralin EN
    Drug - 30 Mar 2023
    Consumer Medicine Information (CMI) about Pyralin EN intended for persons living in Australia.
  • Salazopyrin
    Drug - 30 Mar 2023
    Consumer Medicine Information (CMI) about Salazopyrin intended for persons living in Australia.
  • Repatha
    Drug - 29 Mar 2023
    Consumer Medicine Information (CMI) about Repatha intended for persons living in Australia.
  • Lexapro® (Escitalopram oxalate) Consumer Medicine Information
    Drug - 17 Feb 2023
      Lexapro®
  • Somavert
    Drug - 31 Jan 2023
    Consumer Medicine Information (CMI) about Somavert intended for persons living in Australia.
  • Adenosine Viatris
    Drug - 20 Jan 2023
    Consumer Medicine Information (CMI) about Adenosine Viatris intended for persons living in Australia.
  • Feldene and Feldene-D
    Drug - 29 Dec 2022
    Consumer Medicine Information (CMI) about Feldene and Feldene-D intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback